乳腺原位癌

Virnig BA, Tuttle TM, Shamliyan T, et al. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010 Feb 3;102(3):170-8.

• 全文
• 摘要

Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877.

• 全文
• 摘要

US Preventive Services Task Force. Final recommendation statement: breast cancer screening. February 2016 [internet publication].

• 全文

Margolese RG, Cecchini RS, Julian TB, et al. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet. 2016 Feb 27;387(10021):849-56.

• 摘要

Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009 Apr 1;27(10):1615-20.

• 摘要

1.  Hieken TJ, Cheregi J, Farolan M, et al. Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up. Am J Surg. 2007;194:504-506.

• 摘要

2.  Cocquyt V, Van Belle S. Lobular carcinoma in situ and invasive lobular cancer of the breast. Curr Opin Obstet Gynecol. 2005 Feb;17(1):55-60.

• 摘要

3.  Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018 Jan;68(1):7-30.

• 全文
• 摘要

4.  Li CI, Anderson BO, Daling JR, et al. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 2002 Oct;75(3):259-68.

• 摘要

5.  Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004 Jun 16;96(12):906-20.

• 全文
• 摘要

6.  Camus MG, Joshi MG, Mackarem G, et al. Ductal carcinoma in situ of the male breast. Cancer. 1994 Aug 15;74(4):1289-93.

• 摘要

7.  Virnig BA, Tuttle TM, Shamliyan T, et al. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010 Feb 3;102(3):170-8.

• 全文
• 摘要

8.  Zygogianni AG, Kyrgias G, Gennatas C, et al. Male breast carcinoma: epidemiology, risk factors and current therapeutic approaches. Asian Pac J Cancer Prev. 2012;13(1):15-9.

• 摘要

9.  San Miguel P, Sancho M, Enriquez JL, et al. Lobular carcinoma of the male breast associated with the use of cimetidine. Virchows Arch. 1997 Mar;430(3):261-3.

• 摘要

10.  Olivotto I, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). CMAJ. 2001;165:912-913.

• 全文
• 摘要

11.  Lakhani SR. The transition from hyperplasia to invasive carcinoma of the breast. J Pathol. 1999;187:272-278.

• 摘要

12.  van de Vijver MJ, Peterse JL, Mooi WJ, et al. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med. 1988;319:1239-1245.

• 摘要

13.  Wren BG. The origin of breast cancer. Menopause. 2007;14:1060-1068.

• 摘要

14.  Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst. 2001 Dec 5;93(23):1811-7.

• 全文
• 摘要

15.  White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst. 1990 Oct 3;82(19):1546-52.

• 摘要

16.  Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017 Jun 20;317(23):2402-16.

• 全文
• 摘要

17.  Patel AV, Press MF, Meeske K, et al. Lifetime recreational exercise activity and risk of breast carcinoma in situ. Cancer. 2003 Nov 15;98(10):2161-9.

• 摘要

18.  Trentham-Dietz A, Newcomb PA, Storer BE, et al. Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):697-703.

• 全文
• 摘要

19.  Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998 Mar;62(3):676-89.

• 全文
• 摘要

20.  Birch JM, Blair V, Kelsey AM, et al. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene. 1998 Sep 3;17(9):1061-8.

• 摘要

21.  Brownstein MH, Wolf M, Bikowski JB. Cowden's disease: a cutaneous marker of breast cancer. Cancer. 1978 Jun;41(6):2393-8.

• 摘要

22.  Jackson AW, Muldal S, Ockey CH, et al. Carcinoma of male breast in association with the Klinefelter syndrome. Br Med J. 1965 Jan 23;1(5429):223-5.

• 全文
• 摘要

23.  Izatt L, Greenman J, Hodgson S, et al. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer. Genes Chromosomes Cancer. 1999 Dec;26(4):286-94.

• 摘要

24.  FitzGerald MG, Bean JM, Hegde SR, et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 1997 Mar;15(3):307-10.

• 摘要

25.  Boardman LA, Thibodeau SN, Schaid DJ, et al. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med. 1998 Jun 1;128(11):896-9.

• 摘要

26.  Vasen HF. Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol. 2000 Nov 1;18(21 Suppl):81S-92S.

• 摘要

27.  Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213-8.

• 全文
• 摘要

28.  Chlebowski RT, Aragaki AK, Anderson GL, et al. Low-fat dietary pattern and breast cancer mortality in the Women's Health Initiative randomized controlled trial. J Clin Oncol. 2017 Sep 1;35(25):2919-26.

• 摘要

29.  Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86.

• 摘要

30.  Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006 Nov;42(17):2909-13.

• 全文
• 摘要

31.  Cutuli B, Dilhuydy JM, De Lafontan B, et al. Ductal carcinoma in situ of the male breast: analysis of 31 cases. Eur J Cancer. 1997 Jan;33(1):35-8.

• 摘要

32.  Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010 Jan;7(1):18-27.

• 摘要

33.  Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007 Aug 11;370(9586):485-92.

• 摘要

34.  Oeffinger KC, Fontham ET, Etzioni R, et al; American Cancer Society. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015 Oct 20;314(15):1599-614.

• 全文
• 摘要

35.  Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, et al. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg. 2009 Aug;198(2):262-9.

• 摘要

36.  Peters NH, van Esser S, van den Bosch MA, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer. 2011 Apr;47(6):879-86.

• 摘要

37.  Fancellu A, Turner RM, Dixon JM, et al. Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg. 2015 Jul;102(8):883-93.

• 摘要

38.  Plana MN, Carreira C, Muriel A, et al. Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol. 2012 Jan;22(1):26-38.

• 摘要

39.  Hussain M, Cunnick GH. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast: a review. Eur J Surg Oncol. 2011 Apr;37(4):279-89.

• 摘要

40.  Bruening W, Fontanarosa J, Tipton K, et al. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010 Feb 16;152(4):238-46.

• 摘要

41.  Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997;76(4):494-501.

• 摘要

42.  Moran CJ, Kell MR, Flanagan FL, et al. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. Am J Surg. 2007 Aug;194(2):172-5.

• 摘要

43.  Hammond ME, Hayes DF, Wolff AC, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract. 2010 Jul;6(4):195-7.

• 全文
• 摘要

44.  Franceschi D, Crowe J, Zollinger R, et al. Breast biopsy for calcifications in nonpalpable breast lesions. A prospective study. Arch Surg. 1990;125:170-173.

• 摘要

45.  Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003;186:337-343.

• 摘要

46.  Claus EB. Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians. Fam Cancer. 2001;1:197-206.

• 摘要

47.  Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877.

• 全文
• 摘要

48.  US Preventive Services Task Force. Final recommendation statement: breast cancer screening. February 2016 [internet publication].

• 全文

49.  American College of Obstetricians and Gynecologists. Practice bulletin number 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 2017 Jul;130(1):e1-16.

• 摘要

50.  National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis [internet publication].

• 全文

51.  National Institute for Health and Care Excellence. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. June 2013 [internet publication].

• 全文

52.  Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer. 1986;57:197-208.

• 摘要

53.  Moran MS, Bai HX, Harris EE, et al. ACR appropriateness criteria(®) ductal carcinoma in situ. Breast J. 2012;18:8-15.

• 摘要

54.  Fung E, Hendry J. External beam radiotherapy (EBRT) techniques used in breast cancer treatment to reduce cardiac exposure. Radiography. 2013;19:73-78.

• 全文

55.  National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer [internet publication].

• 全文

56.  Staley H, McCallum I, Bruce J. Postoperative tamoxifen for ductal carcinoma in situ. Cochrane Database Syst Rev. 2012 Oct 17;(10):CD007847.

• 全文
• 摘要

57.  Margolese RG, Cecchini RS, Julian TB, et al. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet. 2016 Feb 27;387(10021):849-56.

• 摘要

58.  Scalliet PG, Kirkove C. Breast cancer in elderly women: can radiotherapy be omitted? Eur J Cancer. 2007 Oct;43(15):2264-9.

• 摘要

59.  Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30;320(13):822-8.

• 摘要

60.  Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009 Apr 1;27(10):1615-20.

• 摘要

61.  Kane RL, Virnig BA, Shamliyan T, et al. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010:130-133.

• 全文
• 摘要

62.  Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012 Apr;13(4):e148-60.

• 摘要

63.  Petrelli F, Barni S. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials. Radiother Oncol. 2011 Aug;100(2):195-9.

• 摘要

64.  Bevers TB, Armstrong DK, Arun B, Carlson RW, et al. Breast cancer risk reduction. J Natl Compr Canc Netw. 2010 Oct;8(10):1112-46.

• 摘要

65.  National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer risk reduction [internet publication].

• 全文

66.  Schwartz GF. The classification and treatment of ductal carcinoma in situ of the breast: Summary of the 1997 and 1999 Consensus Conferences. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002.

67.  Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol. 2008 Mar 10;26(8):1247-52.

• 摘要

68.  Benitez PR, Keisch ME, Vicini F, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007 Oct;194(4):456-62.

• 摘要

69.  ClinicalTrials.gov. Radiation therapy with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone lumpectomy. May 2018 [internet publication].

• 全文

70.  Rowell NP. Are mastectomy resection margins of clinical relevance? A systematic review. Breast. 2010;19:14-22.

• 摘要

71.  Rosso S, Gondos A, Zanetti R, et al. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer. 2010;46:3351-3357.

• 摘要

72.  Pappo I, Wasserman I, Halevy A. Ductal carcinoma in situ of the breast in men: a review. Clin Breast Cancer. 2005;6:310-314.

• 摘要

73.  Narod SA, Iqbal J, Giannakeas V, et al. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015;1:888-896.

• 摘要

74.  Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.

• 摘要

75.  Martino S, Cauley JA, Barrett-Connor E, et al. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst. 2004;96:1751-1761.

• 全文
• 摘要